1 / 13

Theragene: Full-Service CRO for Pre-clinical and Clinical Development

Theragene, founded in 2001 in San Diego, is a comprehensive CRO offering pre-clinical and clinical services worldwide. Their facilities in San Diego and Beijing support operations, collaborations with academic institutions, and key clients in the biopharmaceutical industry. Under the leadership of Jon Berglin and with key personnel including Charles Zhang and John Giammona, Theragene focuses on growth, joint ventures, and delivering top-notch services in bioanalysis, pharmacology, regulatory affairs, and more.

kurtk
Télécharger la présentation

Theragene: Full-Service CRO for Pre-clinical and Clinical Development

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Comprehensive Pre-clinical and Clinical CRO

  2. Theragene Overview • Company founded in 2001, San Diego, CA • Originally focused on vector development for the gene therapy industry • Full Service CRO • Pre-clinical and Clinical Development • Sister company, Theragene Pharmaceuticals

  3. Pre-clinical Development • Pre-clinical Research (CRO) • In Vitro ADMET • Bioanalysis • Bioequivalence/Bioavailability Services (Phase 1) • Toxicology/Pharmacology Services • Pharmacokinetics • Pharmaceutical Analysis

  4. Clinical Development • Clinical Research (CRO) • Regulatory Affairs • Project Management • Site Management • Medical Affairs • Data Management • Statistical Analysis

  5. Theragene Management • Jon Berglin, President & CEO • Charles Zhang, PhD, COO • John Giammona, PhD, SVP-Operations and BD • Steve Davis, Esq. VP-General Counsel • Warren Pleskow, MD, Chief Medical Advisor

  6. Theragene Facilities • San Diego, CA • Beijing, China

  7. Theragene Initiatives • CRO Growth • United States • China • Europe • South America • Joint Ventures • Phase 1 Facilities Established

  8. Theragene Collaborators • Pre-Clinical Services • iPhase Pharma Services, Beijing, China • Zhongshan Pharma SS, Guangzhou, China • Clinical Services • Conventus • Vertexx Data Designs • Comprehensive Clinical Development • Pacific Pharma Services

  9. Theragene Collaborators • Key Academic Collaborators • University of California, San Diego (UCSD) • University of California, Los Angeles (UCLA) • Salk Institute for Biological Studies • The Scripps Research Institute (TSRI) • City of Hope (Duarte, CA) • John Wayne Cancer Institute

  10. Key Customers • Cosmo Bioscience, Inc. • Theragene Pharmaceuticals, Inc. • Eclipse Therapeutics, Inc. • PersImmune, Inc. • The Scripps Research Institute (TSRI)

  11. Theragene Financials • 2011 Projected Revenue: • 2011 Projected EBITDA: • Same Store Growth Projections • Revenue from Chinese Operations

  12. Theragene’s Growth Strategy • Same Store Growth • Emerging Markets • Phase 1 Facilities • Joint Ventures/Collaborations • Strong Marketing Campaign

  13. Conclusions • Full Service Pre-clinical and Clinical CRO • Worldwide growth within 2011 • Increased Joint Ventures/Collaborations • Exponential Financial Growth over the next 5 years • Established as a leader in bridging studies between US and China

More Related